[R01] Unraveling the neural mechanisms for satiety and weight loss by GLP1-based drugs
Ente: National Institute of Diabetes and Digestive and Kidney Diseases
Scadenza: 2030-05-31
Importo max: $747,133
Paese: US
Descrizione
PROJECT SUMMARY
Over the last several decades, obesity rates have been rising, and research has failed to solve this public health
crisis. Now, we are at the precipice of change. Glucagon-like peptide-1 (GLP1)-based obesity drugs have
emerged as a promising strategy for weight loss, and their unprec
Settori: National Institute of Diabetes and Digestive and Kidney Diseases
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.